Phase III results put obinutuzumab in line for approval ...

March is National Kidney Month, a time to shine a light on the thousands of individuals whose lives are deeply affected by ...

New findings from Spherix Global Insights’ Patient Chart Dynamix™: Lupus Nephritis (US), 2025 report reveal a treatment landscape in transition as specialists increasingly incorporate biologics, ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that its abstract detailing clinical results ongoing Phase 1/2 trial ...

Johnson & Johnson’s (J&J) nipocalimab, a potential immunoselective investigational treatment for adults with systemic lupus ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

Now the Vice President of Research at the Lupus Foundation of America, Dr. Buie’s work stems from that curiosity as well as ...

For the millions of people living with lupus – a chronic autoimmune disease that can damage the kidneys, brain and other ...

InvestigateTV+ shares a young mother’s struggle with the debilitating effects of lupus. Plus, we take an in-depth look at what could become a breakthrough treatment.

Johnson & Johnson has won U.S. Food and Drug Administration fast-track designation for its investigational nipocalimab drug in adults with systemic lupus erythematosus, a chronic autoimmune disease.

Lupus, an autoimmune disease characterized by inflammation, can affect the heart and lead to rhythm disturbances, such as arrhythmias. Symptoms of arrhythmia, such as an abnormal heart rate, may ...

Doctors once advised women with lupus not to get pregnant due to the potential risks to mother and baby. But while pregnancy with lupus still carries its own set of risks, most women with lupus can ...